Balaxi Pharmaceuticals Limited

NSE:BALAXI.NS

109.4 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q3
Operating Activities:
Net Income 64.804109.338135.936144.286-413.4381.00282.289154.868141.466127.105121.795120.541107.13783.573109.6101.15387.0314.57624.73911.4110.316.87411.8912.196-1.302-2.164-1.419-3.456-0.661-0.547-0.364-0.312-0.530.116-0.372-0.244-0.3040.0370.807
Depreciation & Amortization 004.8102.85311.8761.8611.90300000000.0190.0190.0190.01900.0090.0090.00900.0050.0050.00500.0030.0030.00300.0050.0050.0050.0040.0040.0040.004
Deferred Income Tax 000000000000000000000000000000000000000
Stock Based Compensation 000000000000000000000000000000000000000
Change In Working Capital 000000000000000-55.298-55.298-55.298-55.2980-9.852-9.852-9.85200.2190.2190.2190-0.503-0.503-0.5030-0.289-0.289-0.2890.710.710.710.71
Accounts Receivables 000000000000000000000000000000000000000
Change In Inventory 000000000000000-2.08-2.08-2.08-2.0800000000000000000000
Change In Accounts Payables 000000000000000000000000000000000000000
Other Working Capital 000000000000000-53.218-53.218-53.218-53.21800000000000000000000
Other Non Cash Items -64.804-109.338-135.936-144.286413.43-81.002-82.289-154.868-141.466-127.105-121.795-120.541-107.137-83.573-109.6-101.153-87.03-14.576-24.739-11.41-10.31-6.874-11.891-2.1961.3022.1641.4193.4560.6610.5470.3640.3120.53-0.1160.3720.2440.304-0.037-0.807
Operating Cash Flow 009.6205.70623.7523.7223.8060000000-35.154-35.154-35.154-35.1540-3.768-3.768-3.7680-1.696-1.696-1.6960-2.478-2.478-2.4780-0.289-0.289-0.2890.5280.5280.5280.528
Investing Activities:
Investments In Property Plant And Equipment 000000000000000-0.457-0.457-0.457-0.4570-0.013-0.013-0.0130-0.027-0.027-0.02700000-0.01-0.01-0.01-0.007-0.007-0.007-0.007
Acquisitions Net 000000000000000000000000000000000000000
Purchases Of Investments 00000000000000000000000000000000000-8.064-8.064-8.064-8.064
Sales Maturities Of Investments 00000000000000000000000000008.228.228.2200000.1050.1050.1050.105
Other Investing Activites 0000000000000000.4570.4570.4570.45700.0130.0130.01300.0270.0270.0270-8.22-8.22-8.2200.010.010.017.9667.9667.9667.966
Investing Cash Flow 000000000000000-0.457-0.457-0.457-0.4570-0.013-0.013-0.0130-0.027-0.027-0.02708.228.228.220-0.01-0.01-0.01-7.966-7.966-7.966-7.966
Financing Activities:
Debt Repayment 000000000000000000000000000000000000000
Common Stock Issued 00000000000000045.2445.2445.2445.2400000000000000000000
Common Stock Repurchased 000000000000000000000000000000000000000
Dividends Paid 00000000000000000000000000000000000-0.205-0.205-0.205-0.205
Other Financing Activities 000000000000000-45.24-45.24-45.24-45.2400000000000000000.2050.2050.2050.205
Financing Cash Flow 00000000000000045.2445.2445.2445.240000000000000000-0.205-0.205-0.205-0.205
Other Information:
Effect Of Forex Changes On Cash 0000000000000000.0640.0640.0640.06400000000000000006.3316.3316.3316.331
Net Change In Cash 009.6205.70623.7523.7223.80600000009.6939.6939.6939.6930-3.781-3.781-3.7810-1.722-1.722-1.72205.7475.7475.7470-0.295-0.295-0.295-1.312-1.312-1.312-1.312
Cash At End Of Period 009.620287.874282.168108.916105.19400000009.959.959.959.9500.2570.2570.25704.0384.0384.03805.765.765.760-0.24-0.24-0.240.0550.0550.0550.055